Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Milliardenmarkt Multiple Sklerose: Neue Therapieform könnte alles verändern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0F57T | ISIN: JP3475350009 | Ticker-Symbol: D4S
Tradegate
03.09.25 | 08:23
20,440 Euro
+0,49 % +0,100
Branche
Pharma
Aktienmarkt
NIKKEI-225
1-Jahres-Chart
DAIICHI SANKYO CO LTD Chart 1 Jahr
5-Tage-Chart
DAIICHI SANKYO CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
20,42020,65008:47
20,42020,69008:44

Aktuelle News zur DAIICHI SANKYO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SaDaiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to Address Persistent Gaps in the Management of Elevated LDL-C914Daiichi Sankyo Europe is pleased to announce the development of a fixed-triple oral combination lipid-lowering tablet of bempedoic acid, ezetimibe, and different doses of a statin, with the potential...
► Artikel lesen
SaDaiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C977Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings...
► Artikel lesen
FrChina to Keep Driving Pharma Industry Transformation, Daiichi Sankyo's China Head Says7
DoMRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate9
25.08.Daiichi Sankyo and AstraZeneca's Datroway receives approval in China12
21.08.Daiichi Sankyo-Aktie kaum gefragt: Kurs bricht um 5,42 Prozent ein (21,82 €)413Im Wertpapierhandel fällt zur Stunde das Wertpapier von Daiichi Sankyo negativ auf. Das Papier verliert deutlich an Wert. Ein Minus von 5,42 Prozent zeigt die Kurstafel für das Wertpapier von Daiichi...
► Artikel lesen
DAIICHI SANKYO Aktie jetzt für 0€ handeln
18.08.Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan348KENILWORTH (NJ) (dpa-AFX) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage...
► Artikel lesen
11.08.Viatris wins FDA nod for generic iron sucrose injection targeting Daiichi's Venofer20
31.07.Daiichi Sankyo reports Q1 results12
31.07.Daiichi Sankyo Q1 Profit Edges Up, Revenues Rise; Confirms FY Outlook474TOKYO (dpa-AFX) - Japanese healthcare firm Daiichi Sankyo Co., Ltd (DSKYF.PK) reported Thursday first-quarter profit attributable to shareholders of 85.50 billion Japanese yen, up 0.1 percent...
► Artikel lesen
18.07.Daiichi Sankyo and AstraZeneca's Enhertu gains breakthrough therapy status29
17.07.AstraZeneca, Daiichi Sankyo get U.S. breakthrough therapy status for Enhertu20
24.06.AstraZeneca, Daiichi's Datroway scores its 2nd FDA approval-this time in lung cancer subset33
24.06.Daiichi Sankyo, AstraZeneca gets U.S. approval for Datroway7
24.06.AZ, Daiichi get Datroway nod in lung cancer on second try2
24.06.FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer4
24.06.AstraZeneca/Daiichi Sankyo's Datroway granted FDA accelerated approval for lung cancer2
24.06.FDA approves AstraZeneca and Daiichi Sankyo's Datroway for NSCLC3
24.06.AstraZeneca To Pay $45 Mln To Daiichi Sankyo As Datroway Gets FDA Approval For Lung Cancer724LONDON (dpa-AFX) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Tuesday that the U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan or Dato-DXd), co-developed...
► Artikel lesen
24.06.US approves AstraZeneca, Daiichi's treatment for lung cancer5
Weiter >>
89 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1